Industry: Longevity Medicine
Estimated Revenue: $1M to $10M
Technology: Intracellular communication
Headquarters: Herzliya, Tel Aviv, Israel
Total Funding: 43000000
Last Funding Date: 2020
Last Funding Type: Series C
Investor Type: Late Stage Venture
Employee Number: 11-50
Investors Number: 7
Founded Date: 2015-01-01